Is Lineage Cell Therapeutics, Inc. overvalued?

Lineage Cell Therapeutics, Inc. (LCTX) — key valuation metrics and fundamentals.

No verdict

Price

$0.97

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$242.1M

Dividend yield

0.0%

Return on equity

-71.1%

Sector

Healthcare

Fair value compares LCTX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.

Related stocks